# British Business Bank

> British Business Bank is a VC fund backing Biotechnology. See 124 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sheffield, United Kingdom
- Total investments: 124
- Last investment: Jul 2026
- Lead investor: 44%
- Last fund: Oct 2023
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/british-business-bank
- X (Twitter): http://twitter.com/britishbbank
- Website: http://british-business-bank.co.uk/
- Facebook: https://www.facebook.com/britishbusinessbank/

British Business Bank is a VC fund in Sheffield focused on Biotechnology and Financial Services. The British Business Bank brings expertise and Government money to the smaller business finance markets. Understanding markets and smaller businesses’ finance needs allows us to design programmes to make the finance markets work better. Investing alongside private sector investors maximises their impact and allows us to reach the full range offinance providers, such as banks, leasing companies, venture capital funds, and web-based platforms.

## Contacts

5 contacts available for British Business Bank. Shizune tracks 12 team members at British Business Bank. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/british-business-bank?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 15 | 12% |
| Financial Services | 12 | 10% |
| Software | 9 | 7% |
| Finance | 8 | 6% |
| Banking | 7 | 6% |

137 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Debt Financing | 26 | 21% |
| Seed | 17 | 14% |
| Funding Round | 13 | 10% |
| Series A | 12 | 10% |
| Series B | 6 | 5% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 79 | 64% |
| Canada | 2 | 2% |
| United States | 2 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Leandros Kalisperas | CIO | 2 | https://shizune.co/investors/profile/leandros-kalisperas-0b56 |
| Charlotte Lawrence | Managing Director and Head of Direct Equity | 23 | https://shizune.co/investors/profile/charlotte-lawrence-f139 |
| Costantino Mariella | Senior Investment Manager | 0 | https://shizune.co/investors/profile/costantino-mariella |
| James Connelly | Non Executive Director | 1 | https://shizune.co/investors/profile/james-connelly |
| Judith Ozcan | Managing Director | 0 | https://shizune.co/investors/profile/judith-ozcan |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Social Investment Scotland | Social Investment Scotland (SIS) is the largest not for profit provider of business loans to the third sector in Scotland as well as being a social enterprise and registered charity. | $4.7M | Debt Financing | Jul 30, 2026 |  |
| Apollo3D | Apollo 3D is an advertising and marketing company that provides 3D scanning, virtual tours, and digital mapping services. | $132.9K | Debt Financing | Jul 29, 2026 |  |
| Draig Therapeutics | Draig Therapeutics is a clinical-stage biopharmaceutical startup dedicated to creating next-generation treatments for serious neuropsychiatric illnesses. | $65M | Series B | Jul 14, 2026 |  |
| SWIG Finance | SWIG Finance provides viable SMEs and start-ups with access to finance through dedicated business loan funds in the South West region. | $23.4M | Debt Financing | Jul 13, 2026 |  |
| Alchemab Therapeutics | Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. | $33.6M | Series A | Jul 09, 2026 |  |
| Alchemab Therapeutics | Alchemab Therapeutics is developing natural protective antibodies designed to keep people free of hard-to-treat diseases. They are building their transformative engine to identify novel drug targets and develop a broad pipeline of novel antibody therapeutics for hard-to-treat cancers, neurodegenerative conditions, and infectious diseases. | $33.6M | Series A | Jul 09, 2026 |  |
| Neuronostics | Neuronostics Ltd is a newly established University of Exeter (UK) spin-out, focussed on the development and commercialisation of a novel and potentially revolutionary seizure susceptibility assessment technology called #BioEP. | $4M | Seed | Jun 30, 2026 |  |
| Propel | Propel Finance specializes in a wide range of asset finance to meet the business needs of individuals and enterprises. | $100.6M | Debt Financing | Jun 16, 2026 |  |
| Allica Bank | Allica Bank provides business banking services focused on supporting established small and medium-sized enterprises through lending, savings, and current account products. Its offering includes commercial mortgages, asset finance, and bridging loans designed to support property investment and operational funding needs. The bank also deliversbusiness current accounts with payment capabilities and tools that help companies manage cash flow. In addition, it provides savings accounts for both businesses and personal customers seeking interest-bearing deposit options. Its services are delivered through a combination of digital tools and relationship-based support to assist financial management and funding access. | $20.1M | Debt Financing | Jun 09, 2026 |  |
| Oxford Quantum Circuits | Oxford Quantum Circuits developing technology using the power of quantum to do things which have never been achieved before, from enabling life-changing drug discoveries to developing new battery technologies. | $350M | Series C | Jun 03, 2026 |  |

10 of 124 investments shown.

## Co-investors
- [Haatch](https://shizune.co/investors/profile/haatch) — VC Fund, 6 deals together
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund, 6 deals together
- [NATO Innovation Fund](https://shizune.co/investors/profile/nato-innovation-fund) — VC Fund, 5 deals together
- [Maven Capital Partners](https://shizune.co/investors/profile/maven-capital-partners) — VC Fund, 4 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 4 deals together
- [Angel Investors Bristol](https://shizune.co/investors/profile/angel-investors-bristol) — VC Fund, 3 deals together

## Similar investors

### Similar stage
- [ENISA](https://shizune.co/investors/profile/enisa-2) — VC Fund
- [Development Bank of Wales](https://shizune.co/investors/profile/development-bank-of-wales) — VC Fund
- [The FSE Group](https://shizune.co/investors/profile/finance-south-east) — VC Fund

## FAQ

### What does British Business Bank invest in?

British Business Bank invests primarily in Biotechnology, Financial Services and Software startups, most often at Debt Financing and Seed stage. Most of the 124 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact British Business Bank?

Public channels for British Business Bank include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at British Business Bank?

The team at British Business Bank includes Leandros Kalisperas (CIO), Charlotte Lawrence (Managing Director and Head of Direct Equity) and Costantino Mariella (Senior Investment Manager), among 12 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co